Showing 46-50 of 93 predictive & prescriptive analytics:
OM1 Unveils Patented, AI-powered Platform to Accelerate Personalized Medicine

April 13, 2023 BusinessWire Read the full release >> The digital phenotyping platform, PhenOM, is delivering personalized and actionable healthcare insights around diagnosis, treatment, risk, utilization, and clinical trials BOSTON–(BUSINESS WIRE)–OM1, a leading real-world data, outcomes and technology company with a focus on chronic conditions, today launched PhenOM™, its artificial intelligence-powered platform for personalized medicine. Calibrated[…]

Dermatology Data Can Direct Policy Priorities, but Gaps Reflect Inequities of Care

American Journal of Managed Care Mar 17, 2023 Christina Mattina Read the Full Article >> Speakers at the American Academy of Dermatology 2023 Annual Meeting highlighted the potential of DataDerm to tell the story of dermatological care in the United States, but some also cautioned that the registry only reflects those who have access to[…]

Interview with OM1’s Jessica Paulus at SCOPE

Published on: March 9, 2023 Applied Clinical Trials Watch the Full Interview >> Key Learning Objectives: Challenges people encounter when working with RWD How can RWD help address gaps in care? How OM1 engages or supports health equity research using RWD

AI Uncovers Other Patients Like You to Support Doctors with ChatGPT

Watch the full interview from Healthcare IT about ChatGPT for un-diagnosed patients with Joseph Zabinski, PhD, Senior Director, AI & Personalized Medicine at OM1. The road to diagnosis can be taxing for patients and once diagnosed, personalized treatment plans are still created with an element of guess work. Automation and artificial intelligence (AI) are the[…]

Informing case management with OMBI® Spine scores

In this case study you will find predictions of which spine procedure patients are at higher risk of excess resource utilization, using only preoperative information, to inform case management. Download >> *Due to proprietary information contained in our materials, we do not currently distribute them to consultants and vendors.

1 … 8 9 10 11 12 … 19